212 related articles for article (PubMed ID: 34205136)
1. Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review.
Sanguedolce F; Zanelli M; Zizzo M; Luminari S; Martino G; Soriano A; Ricci L; Caprera C; Ascani S
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205136
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.
Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888
[TBL] [Abstract][Full Text] [Related]
3. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract][Full Text] [Related]
4. CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.
Weng CY; Ye C; Fan YH; Lv B; Zhang CL; Li M
World J Clin Cases; 2022 May; 10(15):4971-4984. PubMed ID: 35801019
[TBL] [Abstract][Full Text] [Related]
5. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
7. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
9. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
10. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.
Küçük C; Wei L; You H
Front Oncol; 2020; 10():1276. PubMed ID: 32850389
[TBL] [Abstract][Full Text] [Related]
11. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
12. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
[TBL] [Abstract][Full Text] [Related]
13. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
14. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
15. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
Alves de Castro JV; Costa FD; Ferreira CR
Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
[TBL] [Abstract][Full Text] [Related]
16. Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Mimicking Crohn's Disease.
Delgado-de la Mora J; Montante-Montes de Oca D; Ángeles-Ángeles A; Quintanilla de Fend L; Martínez Benitez B
Cureus; 2024 May; 16(5):e60467. PubMed ID: 38882977
[TBL] [Abstract][Full Text] [Related]
17. Indolent T-Cell Lymphoproliferative Disease: A Rare Case of a Benign Lymphoma of the Gastrointestinal Tract With Extra-Gastrointestinal Involvement.
David R; Mishra K; Gilbert ER; Mirza KM; Hendler S
ACG Case Rep J; 2022 Oct; 9(10):e00879. PubMed ID: 36247380
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
[No Abstract] [Full Text] [Related]
19. Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus-encoded RNAs.
Kim EK; Yang WI; Ryu HJ; Ji HL; Yoon SO
Adv Anat Pathol; 2020 Mar; 27(2):75-86. PubMed ID: 31913182
[TBL] [Abstract][Full Text] [Related]
20. Indolent NK-cell lymphoproliferative disorder of the GI tract: a rare indolent neoplasm of the GI tract.
Attieh M; Asakrah S
Blood; 2023 Apr; 141(16):2033. PubMed ID: 37079328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
